Showing 1-4 of 4 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Reprogramming α-Cells into Insulin Producers: From Cellular Mechanisms to Therapeutics | University of Geneva | Pedro Herrera Merino | Cures | 01-August-2026 to 31-July-2029 | $745,158.00 |
| Leveraging Genetic Risk Scores to Screen for Type 1 Diabetes: Predictive Modeling and Cost-Effectiveness | University of Geneva | Lauric Ferrat | Cures | 01-September-2025 to 31-August-2028 | $529,128.00 |
| Cryogel-based, prevascularized biological platform for islet transplantation | University of Geneva | Ekaterine Berishvili | Cures | 01-October-2023 to 30-September-2027 | $621,125.00 |
| Lancet Commission on type 1 diabetes: Defining the Next Century for Type 1 Diabetes Care The Benefits of Looking Backwards for Optimizing Efforts Moving Forward | University of Geneva | David Beran | Mission | 01-August-2024 to 31-July-2026 | $498,168.00 |